Cargando…
Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials
OBJECTIVES: The perioperative, functional, and oncological outcomes of patients with solitary small renal tumors (SRMs) treated with ablation (AT) or partial nephrectomy (PN) remain controversial. The aim of this study was to compare the outcomes of these two surgical techniques. METHODS: In April 2...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331136/ https://www.ncbi.nlm.nih.gov/pubmed/37434978 http://dx.doi.org/10.3389/fonc.2023.1202587 |
_version_ | 1785070197161328640 |
---|---|
author | Wen, Zhi Wang, Li Huang, Jing Liu, Yang Chen, Cai-xia Wang, Chong-jian Chen, Lin-lin Yang, Xue-song |
author_facet | Wen, Zhi Wang, Li Huang, Jing Liu, Yang Chen, Cai-xia Wang, Chong-jian Chen, Lin-lin Yang, Xue-song |
author_sort | Wen, Zhi |
collection | PubMed |
description | OBJECTIVES: The perioperative, functional, and oncological outcomes of patients with solitary small renal tumors (SRMs) treated with ablation (AT) or partial nephrectomy (PN) remain controversial. The aim of this study was to compare the outcomes of these two surgical techniques. METHODS: In April 2023, we conducted a literature search in several widely used databases worldwide, including PubMed, Embase, and Google Scholar. Review Manager was used to compare various parameters. The study was registered with PROSPERO (CRD42022377157). RESULTS: Our final meta-analysis included 13 cohort studies with a total of 2,107 patients. Compared to partial nephrectomy (PN), ablation (AT) had shorter hospital stays (WMD -2.37 days, 95% CI -3.05 to -1.69; p < 0.00001), shorter operating times (WMD -57.06 min, 95% CI -88.92 to -25.19; p = 0.0004), less postoperative creatinine increases (WMD -0.17 mg/dL, 95% CI -0.29 to -0.05; p = 0.006), less postoperative glomerular filtration rate decreases (WMD -9.84 mL/min/1.73 m2, 95% CI -14.25 to -5.44; p < 0.0001), less postoperative new-onset chronic kidney disease (OR 0.33, 95% CI 0.16 to 0.71; p = 0.005), and less intraoperative blood loss (WMD -285.92 ml, 95% CI -428.44 to -143.40; p < 0.0001). The transfusion rate was lower in the ablation group (OR 0.17, 95% CI 0.06 to 0.51; p = 0.001). The risk of local recurrence was higher in the ablation group (OR 2.96, 95% CI 1.27 to 6.89; p = 0.01), while the risk of distant metastasis was higher in the partial nephrectomy group (OR 2.81, 95% CI 1.28 to 6.18; p = 0.01). The intraoperative and postoperative complication rates were lower in the ablation group (OR 0.23, 95% CI 0.08 to 0.62; p = 0.004 and OR 0.21, 95% CI 0.11 to 0.38; p < 0.00001, respectively). However, overall survival, postoperative dialysis rate, and tumor-specific survival were not different between the two groups. CONCLUSIONS: Our data suggest that ablation and partial nephrectomy are equally safe and effective in the treatment of small solitary kidney tumors and are better options for patients with poor preoperative physical condition or poor renal function. |
format | Online Article Text |
id | pubmed-10331136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103311362023-07-11 Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials Wen, Zhi Wang, Li Huang, Jing Liu, Yang Chen, Cai-xia Wang, Chong-jian Chen, Lin-lin Yang, Xue-song Front Oncol Oncology OBJECTIVES: The perioperative, functional, and oncological outcomes of patients with solitary small renal tumors (SRMs) treated with ablation (AT) or partial nephrectomy (PN) remain controversial. The aim of this study was to compare the outcomes of these two surgical techniques. METHODS: In April 2023, we conducted a literature search in several widely used databases worldwide, including PubMed, Embase, and Google Scholar. Review Manager was used to compare various parameters. The study was registered with PROSPERO (CRD42022377157). RESULTS: Our final meta-analysis included 13 cohort studies with a total of 2,107 patients. Compared to partial nephrectomy (PN), ablation (AT) had shorter hospital stays (WMD -2.37 days, 95% CI -3.05 to -1.69; p < 0.00001), shorter operating times (WMD -57.06 min, 95% CI -88.92 to -25.19; p = 0.0004), less postoperative creatinine increases (WMD -0.17 mg/dL, 95% CI -0.29 to -0.05; p = 0.006), less postoperative glomerular filtration rate decreases (WMD -9.84 mL/min/1.73 m2, 95% CI -14.25 to -5.44; p < 0.0001), less postoperative new-onset chronic kidney disease (OR 0.33, 95% CI 0.16 to 0.71; p = 0.005), and less intraoperative blood loss (WMD -285.92 ml, 95% CI -428.44 to -143.40; p < 0.0001). The transfusion rate was lower in the ablation group (OR 0.17, 95% CI 0.06 to 0.51; p = 0.001). The risk of local recurrence was higher in the ablation group (OR 2.96, 95% CI 1.27 to 6.89; p = 0.01), while the risk of distant metastasis was higher in the partial nephrectomy group (OR 2.81, 95% CI 1.28 to 6.18; p = 0.01). The intraoperative and postoperative complication rates were lower in the ablation group (OR 0.23, 95% CI 0.08 to 0.62; p = 0.004 and OR 0.21, 95% CI 0.11 to 0.38; p < 0.00001, respectively). However, overall survival, postoperative dialysis rate, and tumor-specific survival were not different between the two groups. CONCLUSIONS: Our data suggest that ablation and partial nephrectomy are equally safe and effective in the treatment of small solitary kidney tumors and are better options for patients with poor preoperative physical condition or poor renal function. Frontiers Media S.A. 2023-06-26 /pmc/articles/PMC10331136/ /pubmed/37434978 http://dx.doi.org/10.3389/fonc.2023.1202587 Text en Copyright © 2023 Wen, Wang, Huang, Liu, Chen, Wang, Chen and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wen, Zhi Wang, Li Huang, Jing Liu, Yang Chen, Cai-xia Wang, Chong-jian Chen, Lin-lin Yang, Xue-song Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials |
title | Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials |
title_full | Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials |
title_fullStr | Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials |
title_full_unstemmed | Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials |
title_short | Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials |
title_sort | perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331136/ https://www.ncbi.nlm.nih.gov/pubmed/37434978 http://dx.doi.org/10.3389/fonc.2023.1202587 |
work_keys_str_mv | AT wenzhi perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials AT wangli perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials AT huangjing perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials AT liuyang perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials AT chencaixia perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials AT wangchongjian perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials AT chenlinlin perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials AT yangxuesong perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials |